Both in R&D — Physical & Biological Sciences
Charles River Laboratories International vs Medpace Holdings
Over the past year CRL returned +101.3% and MEDP returned +24.2%; their daily moves had a correlation of 0.56.
CRL +101.3% MEDP +24.2%Growth of $1, one year, split-adjusted
| Metric | CRL | MEDP |
|---|---|---|
| Price | $295.96 | $622.11 |
| Market cap | $14.13B | $17.36B |
| Today | +0.47% | +1.00% |
| 1 month | +1.5% | +3.6% |
| 6 months | +85.3% | +35.2% |
| Year to date | +48.4% | +10.8% |
| 1 year | +99.2% | +25.2% |
| Revenue growth (YoY) | −2.7% | +17.2% |
| Gross margin | 36.2% | 28.5% |
| Net margin | −0.1% | 17.2% |
| P/E (TTM) | — | 35.3× |
| Price / sales | 3.5× | 6.2× |
| Net cash | -$2.43B | $502.7M |
| Dividend yield | — | — |
| Volatility (60d) | 39.9% | 37.1% |
| Short % of float | 4.7% | 7.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).